Researchers Identify Immune-Suppressing Target in Glioblastoma: University of Texas
December 24, 2019
December 24, 2019
HOUSTON, Texas, Dec. 24 [TNSmedicalresearch] -- The University of Texas's MD Anderson Cancer Center issued the following news release:
* * *
- Analysis of human tumors, followed by mouse studies, points to treating CD73 macrophages
* * *
Researchers at The University of Texas MD Anderson Cancer Center have identified a tenacious subset of immune macrophages that thwart treatment of glioblastoma with anti-PD-1 checkpoint blockade, elevating a ne . . .
* * *
- Analysis of human tumors, followed by mouse studies, points to treating CD73 macrophages
* * *
Researchers at The University of Texas MD Anderson Cancer Center have identified a tenacious subset of immune macrophages that thwart treatment of glioblastoma with anti-PD-1 checkpoint blockade, elevating a ne . . .